Half-Year Figures: ZEISS Looks back on Good First Six Months Overall
- Half-year revenue reaches 3.2 billion euros (+6% compared to prior year) – EBIT at 455 million euros (+12 million euros compared to prior year), - The Semiconductor Manufacturing Technology and Medical Technology segments contributed in particular to growth in the first six months, - Initial impact of the COVID-19 pandemic felt particularly in Q2, - ZEISS portfolio ensures stability even during the COVID-19 pandemic, - Difficult to form outlook on further progression of fiscal year.